Cambridge Investment Research Advisors
SONM icon

Cambridge Investment Research Advisors’s DNA X Inc SONM Stock Holding History

Cambridge Investment Research Advisors’s Portfolio SONM Stock Details SONM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6
Closed -$6K – 3195
2021
Q2 		$6K Hold
6
– – ﹤0.01% 3082
2021
Q1 		$8K Hold
6
– – ﹤0.01% 2860
2020
Q4 		$7K Hold
6
– – ﹤0.01% 2701
2020
Q3 		$8K Buy
+6
New +$9.64K ﹤0.01% 2509

Other funds holding SONM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
DAS
Dynamic Advisor Solutions Phoenix, Arizona $3.53B AUM 22.61% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return

Cambridge Investment Research Advisors's SONM Position: Q3 2021 in Review

Cambridge Investment Research Advisors sold out of DNA X Inc (SONM) in Q3 2021, closing a stake of 6 shares — an estimated $6K sold.

Cambridge Investment Research Advisors first reported a position in SONM in Q3 2020 and held it in 4 quarters. The position peaked at $8K in Q1 2021. 11 funds tracked by Wall St. Rank hold SONM as of Q3 2021.

  • Cambridge Investment Research Advisors reported no remaining DNA X Inc position as of Q3 2021 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 6 DNA X Inc shares in Q3 2021, an estimated $6K.
  • Cambridge Investment Research Advisors first reported a position in DNA X Inc in Q3 2020 and held it in 4 quarters.
  • Cambridge Investment Research Advisors's DNA X Inc position peaked at $8K in Q1 2021.
  • 11 funds tracked by Wall St. Rank held DNA X Inc as of Q3 2021.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2021, filed 2 Nov 2021.